Search Results 1171-1180 of 13929 for Assay

  1. Minnesota Partnership awards 5 collaborative research grants for 2021 - Mayo Clinic News Network

    The researchers hope to develop a chemical assay that will lead to identifying antibodies that could be used to treat the disease. Development and clinical ...

  2. Clinical studies - Center for Individualized Medicine - Mayo Clinic Research

    The Mayo Clinic Center for Individualized Medicine's clinical studies use genomic products and procedures in new and different ways to diagnose and treat ...

  3. Retroperitoneal Lymph Node Dissection In Treating Patients With Testicular Seminoma - Mayo Clinic

    ... assay) within 14 days of RPLND; Eastern Cooperative Oncology Group (ECOG) performance status =< 1; Ability to understand and the willingness to sign a written ...

  4. Efficacy And Safety Study Of Bb2121 In Subjects With Relapsed And Refractory Multiple Myeloma (KarMMa) - Mayo Clinic

    Serum free light chain (FLC) assay: involved FLC level greater or equal to 10 mg/dL (100 mg/L) provided serum FLC ratio is abnormal. Recovery to Grade 1 or ...

  5. A Study To Evaluate MEDI2228 In Subjects With Relapsed/ Refractory Multiple Myeloma - Mayo Clinic

    Serum free light chain (FLC) assay: involved FLC level ≥ 10 mg/dL provided serum. FLC ratio is abnormal. Subjects must be deemed relapsed/refractory, as ...

  6. Induction Therapy With RO7790121 in Patients With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

    ... assay (ELISA) tests (e.g., T-SPOT® ), with the following exceptions: – Potential participants with a history of Bacillus Calmette-Guérin (BCG) vaccination ...

  7. Study Of Treg Therapy In Subclinical Inflammation In Kidney Transplantation (TASK) - Mayo Clinic

    Negative TB test (PPD, interferon-gamma release assay, ELISPOT testing) within 1 year prior to enrollment. Subjects with a history of TB (positive TB test ...

  8. Phase 1/2 Study Of MRTX1719 In Solid Tumors With MTAP Deletion - Mayo Clinic

    Phase 1 dose escalation only: solid tumor malignancies with homozygous deletion of the CDKN2A gene may be eligible for enrollment if the CDKN2A assay is ...

  9. Colon Melanoma Clinical Trials

    GRAIL is using deep sequencing of circulating cell-free nucleic acids (cfNAs) to develop assays to detect cancer early in blood. The purpose of this study ...

  10. Hypothyroidism (underactive thyroid) - Diagnosis and treatment - Mayo Clinic

    Treatment for hypothyroidism usually includes taking the thyroid hormone medicine levothyroxine (Levo-T, Synthroid, others) every day. This medicine is taken by ...